This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Antibody Aggregation Assesment
Cutting-Edge Antibody Aggregation Assessment: Ensuring Therapeutic Safety and Efficacy!
In the realm of biopharmaceuticals, ensuring the stability and efficacy of therapeutic antibodies is of paramount importance. Are you seeking advanced solutions to evaluate antibody aggregation and optimize drug development? Look no further! Alcyomics is excited to introduce our Antibody Aggregation Assessment services!
Understanding Antibody Aggregation:
Antibody aggregation, the clustering of antibodies, can impact drug efficacy, safety, and immunogenicity. At Alcyomics, we recognize the significance of precise and comprehensive assessment to ensure the success of therapeutic candidates.
Advancing Therapeutic Development:
Our Antibody Aggregation Assessment services offer a robust platform to examine the stability and potential aggregation of therapeutic antibodies. From early development to quality control, our services empower researchers and pharmaceutical companies to make informed decisions.
What services can we offer?
1. Sedimentation velocity-analytic ultra-centrifugation (SV-AUC)
2. Transmission Electron Microscopy (TEM)
3. Aggregation immunogenicity testing
Plus many more
Key Features of Alcyomics' Antibody Aggregation Assessment:
In the realm of biopharmaceuticals, ensuring the stability and efficacy of therapeutic antibodies is of paramount importance. Are you seeking advanced solutions to evaluate antibody aggregation and optimize drug development? Look no further! Alcyomics is excited to introduce our Antibody Aggregation Assessment services!
Understanding Antibody Aggregation:
Antibody aggregation, the clustering of antibodies, can impact drug efficacy, safety, and immunogenicity. At Alcyomics, we recognize the significance of precise and comprehensive assessment to ensure the success of therapeutic candidates.
Advancing Therapeutic Development:
Our Antibody Aggregation Assessment services offer a robust platform to examine the stability and potential aggregation of therapeutic antibodies. From early development to quality control, our services empower researchers and pharmaceutical companies to make informed decisions.
What services can we offer?
1. Sedimentation velocity-analytic ultra-centrifugation (SV-AUC)
2. Transmission Electron Microscopy (TEM)
3. Aggregation immunogenicity testing
Plus many more
Key Features of Alcyomics' Antibody Aggregation Assessment:
Customizable Assays: Tailor experiments to your specific needs, providing valuable insights into antibody aggregation patterns.
Expert Support: Collaborate with our team of biopharmaceutical experts, guiding you through every step of the assessment process.
Cutting-Edge Technology: Benefit from our advanced instrumentation, delivering accurate and reliable results.
Risk Mitigation: Identify and address potential aggregation issues, ensuring drug safety and efficacy.
Exploring Therapeutic Potential:
Whether you're developing monoclonal antibodies, bispecifics, or antibody-drug conjugates, Alcyomics' Antibody Aggregation Assessment is a crucial tool to assess and optimize your therapeutic candidates.
Get in touch at info@alcyomics.com
Expert Support: Collaborate with our team of biopharmaceutical experts, guiding you through every step of the assessment process.
Cutting-Edge Technology: Benefit from our advanced instrumentation, delivering accurate and reliable results.
Risk Mitigation: Identify and address potential aggregation issues, ensuring drug safety and efficacy.
Exploring Therapeutic Potential:
Whether you're developing monoclonal antibodies, bispecifics, or antibody-drug conjugates, Alcyomics' Antibody Aggregation Assessment is a crucial tool to assess and optimize your therapeutic candidates.
Get in touch at info@alcyomics.com
Example data shows size distribution of antibody aggregates at different temperatures and pH.
TEM analysis of antibody clearly demonstrates increased aggregation correlating with increased environmental temperature.
